Chadwick Jeremy G bought KYMR
March 2, 2026 · Form 4 insider transaction
Chadwick Jeremy G bought 12,575 shares of Kymera Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
12,575
Price
$0.00
Total value
N/A
InsiderChadwick Jeremy G
RoleOfficer
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateMarch 2, 2026
Filing dateMarch 4, 2026
Shares owned after79,768
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock upon vesting and settlement. The RSUs shall vest in three equal annual installments following March 3, 2025, subject to the reporting person's continued employment through each vesting date.; This number includes 773 shares and shares acquired under the Registrant's employee stock purchase plan.